Laboratoire de Bioimagerie et Pathologies


Logo Universite de strasbourg


Sur ce site

Sur le Web du CNRS

Accueil du site > Equipe Signalisation tumorale et cibles thérapeutiques > Publications

Publication 2010

2 février 2015

A. AKADDAR, C. DODERER-LANG, M.R. MARZAHN, F. DELALANDE, M. MOUSLI, K. HELLE, A. VAN DORSSELAER, D. AUNIS, B.M. DUNN, M.H. METZ-BOUTIGUE & E. CANDOLFI. Catestatin, an endogenous chromogranin A-derived peptide, inhibits in vitro growth of Plasmodium falciparum. Cell. Mol. Life Sci. 67, 1005-1015, 2010 – IF 6.45

S. OUEDRAOGO, L. BELEMNABA, H. ZAGUE, A. TRAORE, M. LOMPO, I.P. GUISSOU, C. LUGNIER & B. BUCHER. Endothelium-independent vasorelaxation by extract and fractions from Lannea microcarpa Engl. and K. Krause (Anacardiaceae) : possible involvement of phosphodiesterase inhibition. Int. J. Pharmacol. Biol. Sci., 4, 9-16, 2010 – IF n.a.

F.C. BRITO, A.E. KUMMERLE, C. LUGNIER, C.A. FRAGA, E.J. BARREIRO & A.L. MIRANDA. Novel thienylacylhydrazone derivatives inhibit platelet aggregation through cyclic nucleotides modulation and thromboxane A2 synthesis inhibition. Eur. J. Pharmacol. 638, 5-12, 2010 – IF 2.75

R. GUABIRABA, A.L. CAMPANHA-RODRIGUES, A.L. SOUZA, H.C. SANTIAGO, C. LUGNIER, J. ALVAREZ-LEITE, V.S. LEMOS & M.M. TEIXEIRA. The flavonoid dioclein reduces the production of pro-inflammatory mediators in vitro by inhibiting PDE4 activity and scavenging reactive oxygen species. Eur. J. Pharmacol. 633, 85-92, 2010 – IF 2.75

A. HAMADI, T.B. DERAMAUDT, K. TAKEDA & P. RONDE. Hyperphosphorylated FAK delocalizes from focal adhesions to membrane ruffles. J. Oncol. 2010, 932803, 2010 – IF n.a.

T. KERAVIS & C. LUGNIER. Cyclic nucleotide phosphodiesterases (PDE) and peptide motifs. Curr. Pharm. Design 16, 1114-1125, 2010 – IF 3.55

I. LAHMAR, M. GUINARD, A. SAUER, L. MARCELLIN, T. ABDELRAHMAN, M. ROUX, M. MOUSLI, A. MOUSSA, H. BABBA, A.W. PFAFF & E. CANDOLFI. Murine neonatal infection provides an efficient model for congenital ocular toxoplasmosis. Exp. Parasitol. 124, 190-196, 2010 – IF 2.04

A. LIVOLSI, N. NIEDERHOFFER, N. DALI-YOUCEF, W. MOKNI, C. OLEXA-ZORN, J.P. GIES, L. MARCELLIN, J. FELDMAN & P. BOUSQUET. Constitutive overexpression of muscarinic receptors leads to vagal hyperreactivity. PLoS ONE 5, e15618, 2010 IF 4.01

A. LIVOLSI, N. NIEDERHOFFER, N. DALI-YOUCEF, C. RAMBAUD, C. OLEXA-ZORN, W. MOKNI, J.P. GIES & P. BOUSQUET. Cardiac muscarinic receptor overexpression in Sudden Infant Death Syndrome. PLoS ONE 5, e9464, 2010 – IF 4.01

E. MARTINKOVA, A. MAGLOTT, D.Y. LEGER, D. BONNET, M. STIBOROVA, K. TAKEDA, S. MARTIN & M. DONTENWILL. Alpha5beta1 integrin antagonists reduce chemotherapy-induced premature senescence and facilitate apoptosis in human glioblastoma cells. Int. J. Cancer 127, 1240-1248, 2010 – IF 5.50

W. MOKNI, T. KERAVIS, N. ETIENNE-SELLOUM, A. WALTER, M.O. KANE, V.B. SCHINI-KERTH & C. LUGNIER. Concerted regulation of cGMP and cAMP phosphodiesterases in early cardiac hypertrophy induced by angiotensin II. PLoS ONE 5, e14227, 2010 – IF 4.01

S. ONCUL, A.S. KLYMCHENKO, O.A. KUCHERAK, A.P. DEMCHENKO, S. MARTIN, M. DONTENWILL, Y. ARNTZ, P. DIDIER, G. DUPORTAIL & Y. MELY. Liquid ordered phase in cell membranes evidenced by a hydration-sensitive probe : effects of cholesterol depletion and apoptosis. Biochim. Biophys. Acta-Biomembr. 1798, 1436-1443, 2010 – IF 3.80

E. SICK, S. BREHIN, P. ANDRE, G. COUPIN, Y. LANDRY, K. TAKEDA & J.P. GIES. Advanced glycation end products (AGEs) activate mast cells. Br. J. Pharmacol. 161, 442-455, 2010 – IF 4.99